Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 22.01% is 45% below its 5-year average of 39.72%, near the low end of its 5-year range (12.27%–120.61%).
As of the fiscal period ended Friday, July 31, 2026. 33.81% above its 12-month average of 16.45%.
Reported quarterly debt to assets ratio; no daily interpolation. Q1 FY2027 (2026-07-31): 22.01%.
DEBT TO ASSETS RATIO
22.01%
DEBT TO ASSETS RATIO AVG TTM
16.45%
DEBT TO ASSETS RATIO AVG 3Y
30.74%
DEBT TO ASSETS RATIO AVG 5Y
39.72%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+33.81%
CURRENT VS 3Y AVG
-28.40%
CURRENT VS 5Y AVG
-44.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+24353.37%
vs the sector median at left
Kestra Medical Technologies, Ltd.
Market Cap
$1.60B
Debt to Assets Ratio
22.01%
TTM Avg
16.45%
3Y Avg
30.74%
5Y Avg
39.72%
Market Cap
$1.61B
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.62B
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.63B
Debt to Assets Ratio
0.76%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.57B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. (KMTS) | $1.60B | 22.01% | 16.45% | 30.74% | 39.72% |
| Omnicell, Inc. (OMCL)vs › | $1.60B | 0.10% | N/A | N/A | N/A |
| uniQure N.V. (QURE)vs › | $1.61B | 0.06% | N/A | N/A | N/A |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | 0.12% | N/A | N/A | N/A |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 0.22% | N/A | N/A | N/A |
| Septerna Inc (SEPN)vs › | $1.63B | 0.04% | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.63B | 0.76% | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | 0.01% | N/A | N/A | N/A |
| Innoviva, Inc. (INVA)vs › | $1.54B | 0.16% | N/A | N/A | N/A |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | 0.84% | N/A | N/A | N/A |
Debt/Assets
22.0%
Debt/Equity
0.34
Current Ratio
4.69
Interest Coverage
-17.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-07-31 | 22.01% |
| 2026-04-30 | 13.05% |
| 2026-01-31 | 12.27% |
| 2025-10-31 | 18.16% |
| 2025-07-31 | 16.74% |
| 2025-04-30 | 14.98% |
| 2025-01-31 | 43.16% |
| 2024-10-31 | 37.96% |
| 2024-04-30 | 98.30% |
| 2021-07-31 | 120.61% |
